Pfizer, Eli Lilly, Bristol-Myer and J&J initiated with buy ratings by Goldman Sachs By: MarketWatch May 28, 2019 at 15:02 PM EDT Goldman Sachs started coverage of some big drug stocks on Tuesday in a bullish note. Read More >> Related Stocks: Amgen Bristol-Myers Squibb Eli Lilly Gilead Sciences Johnson & Johnson Merck & Co Pfizer Regeneron Pharmaceuticals